 <h1>Qsymia Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>phentermine / topiramate</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about phentermine / topiramate. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Qsymia.</p><h2>In Summary</h2><p><b>Common side effects of Qsymia include:</b> constipation, insomnia, nasopharyngitis, paresthesia, mood disorder, sleep disorder, and xerostomia. <b>Other side effects include:</b> urinary tract infection, anxiety, blurred vision, depression, dizziness, fatigue, influenza, nausea, increased serum creatinine, and dysgeusia.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to phentermine / topiramate: oral capsule extended release</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, phentermine/topiramate may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking phentermine / topiramate:</p><p>
<i>Less common</i>
</p><ul>
<li>Chest discomfort</li>
<li>convulsions</li>
<li>decreased urine</li>
<li>fast, irregular, pounding, or racing heartbeat or pulse</li>
<li>loss of appetite</li>
<li>mood changes</li>
<li>muscle pain or cramps</li>
<li>nausea or vomiting</li>
<li>numbness or tingling in the hands, feet, or lips</li>
<li>shortness of breath</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Blood in the urine</li>
<li>pain in the groin or genitals</li>
<li>sharp back pain just below the ribs</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Blistering, peeling, or loosening of the skin</li>
<li>blisters on the mouth, trunk, scalp, or other areas</li>
<li>blurred or decreased vision</li>
<li>chest pain</li>
<li>chills or shivering</li>
<li>clumsiness</li>
<li>continuing nausea or vomiting</li>
<li>cough or sore throat</li>
<li>dark urine</li>
<li>diarrhea or light-colored stools</li>
<li>dizziness</li>
<li>headache</li>
<li>increase in the frequency of seizures</li>
<li>irregular heartbeat</li>
<li>itching</li>
<li>joint or muscle pain</li>
<li>loss of appetite</li>
<li>low body temperature</li>
<li>muscle aches or weakness</li>
<li>pain in the shoulders, arms, jaw, or neck</li>
<li>red skin lesions, often with a purple center</li>
<li>red, irritated eyes</li>
<li>shakiness in the legs, arms, hands, or feet</li>
<li>sores, ulcers, or white spots in the mouth or on the lips</li>
<li>sweating</li>
<li>swelling of the face</li>
<li>tiredness and weakness</li>
<li>trouble thinking, speaking, or walking</li>
<li>upper right abdominal or stomach pain</li>
<li>weak or feeble pulse</li>
<li>weight gain</li>
<li>yellow eyes or skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of phentermine / topiramate may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Back pain</li>
<li>change in taste</li>
<li>difficulty having a bowel movement (stool)</li>
<li>ear congestion</li>
<li>fear or nervousness</li>
<li>loss of taste</li>
<li>loss of voice</li>
<li>memory problems</li>
<li>pain or tenderness around the eyes and cheekbones</li>
<li>sneezing</li>
<li>stuffy or runny nose</li>
<li>trouble sleeping</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Belching</li>
<li>cramps</li>
<li>decreased appetite</li>
<li>dry eyes</li>
<li>eye pain</li>
<li>hair loss</li>
<li>heartburn or indigestion</li>
<li>heavy bleeding</li>
<li>irritability</li>
<li>rash</li>
<li>stomach discomfort, upset, or pain</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Bloating</li>
<li>false or unusual sense of well-being</li>
<li>feeling that others are watching you or controlling your behavior</li>
<li>feeling that others can hear your thoughts</li>
<li>feeling, seeing, or hearing things that are not there</li>
<li>hives or welts</li>
<li>change in sexual ability, desire, drive, or performance</li>
<li>severe mood or mental changes</li>
<li>unusual behavior</li>
</ul><p>
<!-- end oral capsule extended release --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to phentermine / topiramate: oral capsule extended release</i></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Paraesthesia (up to 19.9%), headache (up to 10.6%)</p>
<p><b>Common</b> (1% to 10%): Dysgeusia, dizziness, hypoesthesia, disturbance in attention, cognitive impairment</p>
<p></p>
<p>Phentermine:</p>
<p><b>Postmarketing reports</b>: Euphoria, psychosis, tremor<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, anxiety, depression/mood problems, irritability</p>
<p><b>Postmarketing reports</b>: Suicidal ideation, suicidal behavior</p>
<p></p>
<p>Phentermine:</p>
<p><b>Postmarketing reports</b>: Libido changes, impotence<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Decreased serum bicarbonate (up to 12.8%)</p>
<p><b>Common</b> (1% to 10%): Hypokalemia, decreased serum potassium, decreased appetite</p>
<p></p>
<p>Topiramate:</p>
<p><b>Postmarketing reports</b>: Hyperammonemia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Elevated serum creatinine, nephrolithiasis<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Elevated resting heart rate (up to 77.7%)</p>
<p><b>Common</b> (1% to 10%): Palpitations</p>
<p></p>
<p>Phentermine:</p>
<p><b>Postmarketing reports</b>: Elevated blood pressure, ischemic events<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Blurred vision, dry eye, eye pain</p>
<p><b>Postmarketing reports</b>: Acute angle closure glaucoma, increased intraocular pressure</p>
<p></p>
<p>Topiramate:</p>
<p><b>Postmarketing reports</b>: Maculopathy<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue, thirst, chest discomfort, procedural pain</p>
<p></p>
<p>Topiramate:</p>
<p><b>Postmarketing reports</b>: Hypothermia<sup>[Ref]</sup></p><h3>General</h3><p>Common adverse reactions occurring at a rate of 5% or more and at a rate of at least 1.5 times placebo include paraesthesia, dizziness, dysgeusia, insomnia, constipation, and dry mouth.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Alopecia, rash</p>
<p></p>
<p>Topiramate:</p>
<p><b>Postmarketing reports</b>: Bullous skin reactions (including erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis), pemphigus<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Dry mouth (up to 19.1%), constipation (up to 16.1%)</p>
<p><b>Common</b> (1% to 10%): Nausea, diarrhea, gastroesophageal reflux disease, dyspepsia, oral paraesthesia, gastroenteritis</p>
<p></p>
<p>Topiramate:</p>
<p><b>Postmarketing reports</b>: Pancreatitis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Dysmenorrhea, urinary tract infection<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Topiramate:</p>
<p><b>Postmarketing reports</b>: Hepatic failure (including fatalities), hepatitis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Phentermine:</p>
<p><b>Postmarketing reports</b>: Urticaria<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, extremity pain, muscle spasms, musculoskeletal pain, neck pain<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory tract infection (up to 15.8%), nasopharyngitis (up to 12.5%)</p>
<p><b>Common</b> (1% to 10%): Sinusitis, bronchitis, cough, sinus congestion, pharyngolaryngeal pain, nasal congestion<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Qsymia (phentermine-topiramate)." Vivus Inc, Mountain View, CA. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Qsymia (phentermine / topiramate)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>545 Reviews</li>
<li>Drug class: anorexiants</li>
<li>FDA Alerts (1)</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Qsymia &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Weight Loss</li>
<li>Obesity</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to phentermine / topiramate: oral capsule extended release</i></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Paraesthesia (up to 19.9%), headache (up to 10.6%)</p><p><b>Common</b> (1% to 10%): Dysgeusia, dizziness, hypoesthesia, disturbance in attention, cognitive impairment</p><p></p><p>Phentermine:</p><p><b>Postmarketing reports</b>: Euphoria, psychosis, tremor<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Insomnia, anxiety, depression/mood problems, irritability</p><p><b>Postmarketing reports</b>: Suicidal ideation, suicidal behavior</p><p></p><p>Phentermine:</p><p><b>Postmarketing reports</b>: Libido changes, impotence<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Decreased serum bicarbonate (up to 12.8%)</p><p><b>Common</b> (1% to 10%): Hypokalemia, decreased serum potassium, decreased appetite</p><p></p><p>Topiramate:</p><p><b>Postmarketing reports</b>: Hyperammonemia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Elevated serum creatinine, nephrolithiasis<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Elevated resting heart rate (up to 77.7%)</p><p><b>Common</b> (1% to 10%): Palpitations</p><p></p><p>Phentermine:</p><p><b>Postmarketing reports</b>: Elevated blood pressure, ischemic events<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Blurred vision, dry eye, eye pain</p><p><b>Postmarketing reports</b>: Acute angle closure glaucoma, increased intraocular pressure</p><p></p><p>Topiramate:</p><p><b>Postmarketing reports</b>: Maculopathy<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue, thirst, chest discomfort, procedural pain</p><p></p><p>Topiramate:</p><p><b>Postmarketing reports</b>: Hypothermia<sup>[Ref]</sup></p><h3>General</h3><p>Common adverse reactions occurring at a rate of 5% or more and at a rate of at least 1.5 times placebo include paraesthesia, dizziness, dysgeusia, insomnia, constipation, and dry mouth.<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Alopecia, rash</p><p></p><p>Topiramate:</p><p><b>Postmarketing reports</b>: Bullous skin reactions (including erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis), pemphigus<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Dry mouth (up to 19.1%), constipation (up to 16.1%)</p><p><b>Common</b> (1% to 10%): Nausea, diarrhea, gastroesophageal reflux disease, dyspepsia, oral paraesthesia, gastroenteritis</p><p></p><p>Topiramate:</p><p><b>Postmarketing reports</b>: Pancreatitis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Dysmenorrhea, urinary tract infection<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Topiramate:</p><p><b>Postmarketing reports</b>: Hepatic failure (including fatalities), hepatitis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Phentermine:</p><p><b>Postmarketing reports</b>: Urticaria<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, extremity pain, muscle spasms, musculoskeletal pain, neck pain<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory tract infection (up to 15.8%), nasopharyngitis (up to 12.5%)</p><p><b>Common</b> (1% to 10%): Sinusitis, bronchitis, cough, sinus congestion, pharyngolaryngeal pain, nasal congestion<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Qsymia (phentermine-topiramate)." Vivus Inc, Mountain View, CA. </p><h2>More about Qsymia (phentermine / topiramate)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>545 Reviews</li>
<li>Drug class: anorexiants</li>
<li>FDA Alerts (1)</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Qsymia &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Weight Loss</li>
<li>Obesity</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>